Literature DB >> 29733790

PI-RADS v2: Current standing and future outlook.

Clayton P Smith1, Barış Türkbey1.   

Abstract

The Prostate Imaging-Reporting and Data System (PI-RADS) was created in 2012 to establish standardization in prostate multiparametric magnetic resonance imaging (mpMRI) acquisition, interpretation, and reporting. In hopes of improving upon some of the PI-RADS v1 shortcomings, the PI-RADS Steering Committee released PI-RADS v2 in 2015. This paper reviews the accuracy, interobserver agreement, and clinical outcomes of PI-RADS v2 and comments on the limitations of the current literature. Overall, PI-RADS v2 shows improved sensitivity and similar specificity compared to PI-RADS v1. However, concerns exist regarding interobserver agreement and the heterogeneity of the study methodology.

Year:  2018        PMID: 29733790      PMCID: PMC5937636          DOI: 10.5152/tud.2018.12144

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  43 in total

1.  Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.

Authors:  L Schimmöller; M Quentin; C Arsov; R S Lanzman; A Hiester; R Rabenalt; G Antoch; P Albers; D Blondin
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

Review 2.  Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis.

Authors:  Sungmin Woo; Chong Hyun Suh; Sang Youn Kim; Jeong Yeon Cho; Seung Hyup Kim
Journal:  Eur Urol       Date:  2017-02-11       Impact factor: 20.096

3.  PIRADS 2.0: what is new?

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Diagn Interv Radiol       Date:  2015 Sep-Oct       Impact factor: 2.630

4.  Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone?

Authors:  Barry G Hansford; Yahui Peng; Yulei Jiang; Michael W Vannier; Tatjana Antic; Stephen Thomas; Stephanie McCann; Aytekin Oto
Journal:  Radiology       Date:  2015-01-05       Impact factor: 11.105

5.  Assessment of PI-RADS v2 for the Detection of Prostate Cancer.

Authors:  Moritz Kasel-Seibert; Thomas Lehmann; René Aschenbach; Felix V Guettler; Mohamed Abubrig; Marc-Oliver Grimm; Ulf Teichgraeber; Tobias Franiel
Journal:  Eur J Radiol       Date:  2016-01-19       Impact factor: 3.528

6.  Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis.

Authors:  Daniel Junker; Michael Quentin; Udo Nagele; Michael Edlinger; Jonathan Richenberg; Georg Schaefer; Michael Ladurner; Werner Jaschke; Wolfgang Horninger; Friedrich Aigner
Journal:  World J Urol       Date:  2014-08-01       Impact factor: 4.226

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

9.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

10.  Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2.

Authors:  Susanne Tewes; Nikolaj Mokov; Dagmar Hartung; Volker Schick; Inga Peters; Peter Schedl; Stefanie Pertschy; Frank Wacker; Götz Voshage; Katja Hueper
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

View more
  3 in total

Review 1.  PI-RADS: what is new and how to use it.

Authors:  Silvina P Dutruel; Sunil Jeph; Daniel J A Margolis; Natasha Wehrli
Journal:  Abdom Radiol (NY)       Date:  2020-12

2.  Improving the detection rate of prostate cancer in the gray zone of PI-RADS v2 and serum tPSA by using prostate-specific antigen-age volume.

Authors:  Yuan-Fei Lu; Qian Zhang; Hai-Yan Chen; Jie-Yu Chen; Yao Pan; Cong-Cong Xu; Jian-Xia Xu; Ri-Sheng Yu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer.

Authors:  Mou Li; Ling Yang; Yufeng Yue; Jingxu Xu; Chencui Huang; Bin Song
Journal:  Front Oncol       Date:  2021-02-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.